Homepage Bottom Left
-
Best wishes from the CHS!
Please CLICK HERE to read a special message from CHS President, Emil Wijnker, and Chief Executive Officer, Sarah Ford.
-
CHS survey of people with hemophilia A and their caregivers
In June and July 2024, the Canadian Hemophilia Society conducted an online survey regarding the lived experience of people with hemophilia A and their caregivers....
-
Rendez-vous 2025
The Canadian Hemophilia Society is delighted to invite you to attend Rendez-vous 2025 coming up May 1-4, 2025, in Winnipeg. CLICK HERE for a glimpse at the...
-
Biomarin limits marketing of its FVIII gene therapy, Roctavian
SAN RAFAEL, California, August 5, 2024 — Biomarin has announced that it will limit commercial, research and manufacturing programs for its factor VIII gene therapy...
-
Novel treatments in bleeding disorders: The European Haemophilia Consortium Review
CLICK HERE to access the 2024 ISSUE TWO of the periodic review of novel treatments in hemophilia and other bleeding disorders by the European Haemophilia...